Search

everythinglearnresearchcommunity

for

Search:↓

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Hormone therapy can improve sexual health and quality of life for women 70 and older.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Most patients improved with oral contraceptives, but some needed additional treatment.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hirsutism treatment should focus more on patient needs and quality of life.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Glucocorticoid and mineralocorticoid therapy effectively manage Congenital Adrenal Hyperplasia symptoms but have limitations.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Androgens, male hormones, play a role in both men and women's health, and testosterone therapy can help women with low levels, but it's not suitable for pregnant or lactating women, or those with certain conditions.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.